Bill Clinton Supports Weed After Years Of Claiming He “Didn’t Inhale.”

( Bill Clinton famously (and questionable) stated he experimented with marijuana but “didn’t inhale.”

This week, the disgraced former president endorsed legal marijuana.
Clinton lauded “extremely positive” CBD pain study results on Tuesday. CBD can relieve tension and anxiety, which might have personal ramifications for Clinton, who is married to a scorned and brutally ambitious woman whose lifelong aim was foiled by a reality TV star who didn’t even want to be president.

Clinton said he tried marijuana in England and didn’t enjoy it in a 1992 interview. “I didn’t inhale or try again.” The statements were widely derided then and after that. This was when cultural elites decided mocking Democrats was not “comedy.” Clinton’s ludicrous assertion is another reason he’s called “Slick Willie.”

Later, he was impeached and disbarred for perjury.

Clinton’s response to the CBD trials—conducted by NYU and TR Processing LLC—included a questionable assertion about the Clinton Foundation’s participation in the opiate problem. The Clintons’ controversial organization, which has struggled to generate money since Hillary Clinton’s 2016 presidential race, has “worked for years to minimize opioid addiction and mortality,” claimed the former president. He supports CBD and “non-addictive alternatives.”

This assertion is flawed. Several members of the Sackler family, the Perdue Pharma dynasty often blamed for the opioid epidemic, are Clinton Foundation supporters.
Dr. Mortimer Sackler, who co-founded the firm in 1952, gave $25,000 to $50,000 before his 2010 death. He wasn’t the only member of the opioid dynasty to fund the Clintons. Jonathan and Jillian Sackler, Mortimer’s nephew and sister-in-law contributed to Hillary’s 2008 campaign.

During the Clinton era, Perdue Pharma made billions marketing the addictive drug OxyContin. Purdue Pharma agreed to pay a $6 billion settlement for its part in the opioid crisis after securing immunity for the Sackler family.

In 2015, the Clinton Foundation partnered with Spencer Williamson, CEO of a pharmaceutical business under investigation for price gouging. In 2017, Virginia-based Kaleo Pharmaceuticals raised the price of its Evzio auto-injector by 680% over three years.

The Clinton Foundation has dwindled. Donations and profitable partnerships are few. The so-called charity raised $62.9 million in 2016 when Hillary ran for president but just $16.3 million in 2020.